{"result": "(\"entity\"<|>NIÑOS<|>PERSON<|>Children who may require nutritional support and monitoring due to various health conditions.)\n##\n(\"entity\"<|>VÍAS<|>ORGANIZATION<|>Refers to the routes of administration for nutritional support, which can include various types of access points for intravenous therapy.)\n##\n(\"entity\"<|>COMPETENCIAS<|>EVENT<|>The skills and evaluations required for monitoring and managing nutritional support in patients.)\n##\n(\"entity\"<|>VITAMINAS<|>ORGANIZATION<|>Essential nutrients that need to be monitored in patients receiving long-term nutritional support.)\n##\n(\"entity\"<|>ELEMENTOS TRAZA<|>ORGANIZATION<|>Trace elements that are crucial for patients on nutritional support and require regular monitoring.)\n##\n(\"entity\"<|>SÍNDROME DE REALIMENTACIÓN<|>EVENT<|>A condition that may occur in patients who are being reintroduced to nutrition after a period of malnutrition, requiring careful management.)\n##\n(\"entity\"<|>ANÁLISIS<|>ORGANIZATION<|>Refers to the various laboratory tests performed to monitor the health status of patients receiving nutritional support.)\n##\n(\"entity\"<|>CATÉTERES<|>ORGANIZATION<|>Devices used for intravenous access in patients receiving nutritional support, which can lead to complications.)\n##\n(\"relationship\"<|>NIÑOS<|>NUTRICIÓN PARENTERAL<|>Children may require nutritional support due to various health issues, necessitating careful monitoring<|>8)\n##\n(\"relationship\"<|>VÍAS<|>NUTRICIÓN PARENTERAL<|>Different routes of administration are critical for effective nutritional support<|>7)\n##\n(\"relationship\"<|>COMPETENCIAS<|>NUTRICIÓN PARENTERAL<|>Skills and evaluations are essential for the effective management of nutritional support<|>6)\n##\n(\"relationship\"<|>VITAMINAS<|>NUTRICIÓN PARENTERAL<|>Vitamins must be monitored in patients receiving nutritional support to prevent deficiencies<|>6)\n##\n(\"relationship\"<|>ELEMENTOS TRAZA<|>NUTRICIÓN PARENTERAL<|>Trace elements are necessary for patients on nutritional support and require regular monitoring<|>6)\n##\n(\"relationship\"<|>SÍNDROME DE REALIMENTACIÓN<|>NUTRICIÓN PARENTERAL<|>Refeeding syndrome is a potential complication in patients transitioning back to nutrition<|>5)\n##\n(\"relationship\"<|>ANÁLISIS<|>NUTRICIÓN PARENTERAL<|>Laboratory tests are crucial for monitoring the health of patients receiving nutritional support<|>6)\n##\n(\"relationship\"<|>CATÉTERES<|>NUTRICIÓN PARENTERAL<|>Catheters are used for administering nutritional support and can lead to complications<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: paciente con NP de larga duración y/o domiciliaria, así como en aquellos con afectación hepática importante asociada al uso de NP.\n\nMuchos de los pacientes que reciben NP reciben además otras medicaciones intravenosas; esto plantea con frecuencia preguntas acerca de la estabilidad de estos fármacos con las soluciones de NP, sobre todo en aquellas situaciones en que no se dispone de múltiples vías o de catéteres de varias luces. Para obtener una información actualizada sobre el tema se recomienda recurrir al Handbook of injectable drugs58. Siempre que sea posible es recomendable utilizar una vía o una de las luces del catéter exclusivamente para la NP. Cuando esto no sea posible, la administración de fármacos debe hacerse en Y59. Solo excepcionalmente algunos fármacos pueden incluirse en la bolsa de NP, como es el caso de la insulina, la heparina, la ranitidina o análogos de la somatostatina60.\n\n## 9. Monitorización\n\nLa monitorización de la NP pasa por una valoración inicial completa antes de su inicio, en la que se incluirán tanto la propia indicación de la NP, como el estado nutricional del niño, el tipo de acceso venoso y una serie de controles analíticos que se detallan en la tabla 11. Las complicaciones de la nutrición parenteral pueden minimizarse cuando se hace una indicación adecuada, se elige una mezcla de nutrientes equilibrada y se vigila estrechamente la respuesta del paciente. La frecuencia con la que es preciso obtener determinaciones analíticas en el seguimiento dependerá tanto de la situación clínica como de la duración del soporte nutricional. Así, los enfermos con pérdidas aumentadas de líquidos (por ejemplo, por una sonda o un dre-\n\n| Tabla 11. Monitorización de la NP en niños. |\n|-------------------------------------------|\n| A. Control clínico |\n| · Balance hídrico diario |\n| · Antropometría (peso, talla, perímetro cefálico) |\n| B. Control analítico |\n| · Hemograma con recuento diferencial |\n| · Electrolitos |\n| · Urea/creatinina |\n| · Glucosa en sangre |\n| · Equilibrio ácido-base |\n| · Calcio/fósforo |\n| · Proteínas totales/Albúmina |\n| · Prealbúmina |\n| · Enzimas hepáticas y bilirrubina |\n| · Colesterol y triglicéridos |\n| · Glucosa, electrolitos y cuerpos cetónicos en orina |\n\nEstos parámetros deben realizarse al inicio de la NP y posteriormente con frecuencia variable según la situación clínica del paciente (por ejemplo 2 o 3 veces a la semana inicialmente). Si la NP se prolonga durante meses hay que monitorizar también oligoelementos, vitaminas, mineralización y edad ósea y estudio de coagulación (estudio de factores de riesgo trombótico).\n\nnaje) o con fallo de algún órgano requieren controles más frecuentes. También es el caso de los pacientes muy desnutridos, que pueden presentar un síndrome de realimentación. Mientras que en el caso de los recién nacidos se minimizará el número de las determinaciones analíticas o, en caso de realizarlas, se preferirá el uso de micrométodos que utilizan escasa cantidad de sangre.\n\nCuando se trata de pacientes con NP domiciliaria (NPD) o prolongada, además de las determinaciones habituales, se monitorizarán los niveles de vitaminas y elementos traza61, 62.\n\nAdemás, el equipo médico responsable del soporte nutricional ha de realizar evaluaciones periódicas de la situación nutricional, así como del cumplimiento de los objetivos terapéuticos marcados al inicio del soporte. Se valorará la retirada de la NP cuando se hayan conseguido dichos objetivos y el paciente sea capaz de recibir por vía digestiva un aporte suficiente de nutrientes (por encima de dos tercios de los requerimientos estimados) o bien cuando sea una medida terapéutica fútil.\n\n## 10. Complicaciones\n\nPodemos clasificar las complicaciones en cuatro grupos: las relacionadas con los CVC, las complicaciones metabólicas, las dependientes de la estabilidad de las soluciones y de las interacciones con fármacos y las psicosociales.\n---\nTema 55. Nutrición parenteral en el paciente pediátrico: vías y fórmulas 873\n\n## 10.1. Complicaciones relacionadas con los catéteres\n\n### 10.1.1. Complicaciones técnicas relacionadas con la inserción\n\nLa frecuencia de este tipo de complicaciones es de alrededor del 4%63. Entre ellas destacan: el neumotórax, el hemotórax, la laceración de un vaso, las arritmias, la perforación cardíaca con taponamiento, el embolismo aéreo, la lesión de un plexo nervioso o la localización anómala del catéter64. La inserción\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional support provided intravenously to patients, particularly in pediatric cases, involving careful monitoring and management of various parameters.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>A patient receiving nutritional support, particularly those with long-term or home-based nutritional needs.)\n##\n(\"entity\"<|>HANDBOOK OF INJECTABLE DRUGS<|>ORGANIZATION<|>A reference guide providing updated information on the stability of drugs used in conjunction with nutritional support solutions.)\n##\n(\"entity\"<|>ENFERMO<|>PERSON<|>A patient who may experience complications related to nutritional support, requiring careful monitoring and management.)\n##\n(\"entity\"<|>CVC<|>ORGANIZATION<|>Central Venous Catheters used for administering nutritional support, which can lead to various complications.)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN PARENTERAL<|>Patients receive nutritional support through parenteral means, necessitating careful monitoring and management<|>8)\n##\n(\"relationship\"<|>HANDBOOK OF INJECTABLE DRUGS<|>NUTRICIÓN PARENTERAL<|>The Handbook provides essential information regarding the stability of drugs used in nutritional support<|>7)\n##\n(\"relationship\"<|>ENFERMO<|>NUTRICIÓN PARENTERAL<|>Patients may experience complications related to nutritional support, requiring ongoing evaluation<|>6)\n##\n(\"relationship\"<|>CVC<|>NUTRICIÓN PARENTERAL<|>CVCs are used in the administration of nutritional support, which can lead to complications<|>5)\n<|COMPLETE|>"}]}